deltatrials
Completed PHASE3 NCT00000599

Cholesterol-Lowering Atherosclerosis Study (CLAS)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Arterial Occlusive Diseases Atherosclerosis Cardiovascular Diseases Carotid Artery Diseases Cerebral Arteriosclerosis Cerebrovascular Disorders Coronary Arteriosclerosis Coronary Disease Heart Diseases Myocardial Ischemia
Interventions colestipol diet, fat-restricted niacin
Updated 5 times since 2017 Last updated: Dec 12, 2013 Started: Jun 30, 1980 Completion: Nov 30, 1994

Listed as NCT00000599, this PHASE3 trial focuses on Arterial Occlusive Diseases and Atherosclerosis and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 5 times since 1980, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jun 1980

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.